Technical Analysis for SRTS - Sensus Healthcare, Inc.

Grade Last Price % Change Price Change
grade D 5.71 6.33% 0.34
SRTS closed up 6.33 percent on Tuesday, May 21, 2019, on 56 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical SRTS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 6.33%
NR7 Range Contraction 6.33%
Inside Day Range Contraction 6.33%
Oversold Stochastic Weakness 6.33%
Spinning Top Other 3.35%
Lower Bollinger Band Walk Weakness 3.35%
Outside Day Range Expansion 3.35%

Older signals for SRTS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.
Medicine Cancer Organ Systems Radiation Radiation Therapy Melanoma Skin Cancer Keloid Keloids
Is SRTS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 15 Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference
May 14 The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings
May 13 72 Biggest Movers From Friday
May 12 Sensus Healthcare's (SRTS) CEO Joe Sardano on Q1 2019 Results - Earnings Call Transcript
May 10 Edited Transcript of SRTS earnings conference call or presentation 9-May-19 8:30pm GMT
May 9 Sensus Healthcare misses by $0.10, misses on revenue
May 9 Sensus Healthcare Reports First Quarter 2019 Financial Results
May 8 Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
May 7 Does The Data Make Sensus Healthcare, Inc. (NASDAQ:SRTS) An Attractive Investment?
Apr 29 The Prognosis For Sensus Healthcare
See more SRTS news...
Indicators
Indicator Value
52 Week High 9.23
52 Week Low 5.2201
Average Volume 45,450
200-Day Moving Average 6.9473
50-Day Moving Average 6.6274
20-Day Moving Average 6.003
10-Day Moving Average 5.6635
Average True Range 0.3723
ADX 18.38
+DI 21.0216
-DI 19.5638
Chandelier Exit (Long, 3 ATRs ) 5.6431
Chandelier Exit (Short, 3 ATRs ) 6.337
Upper Bollinger Band 6.8599
Lower Bollinger Band 5.1461
Percent B (%b) 0.33
BandWidth 28.549059
MACD Line -0.3188
MACD Signal Line -0.2968
MACD Histogram -0.022
Fundamentals Value
Market Cap 77.02 Million
Num Shares 13.5 Million
EPS -0.18
Price-to-Earnings (P/E) Ratio -31.72
Price-to-Sales 4.61
Price-to-Book 6.29
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.22
Resistance 3 (R3) 6.17 5.96 6.14
Resistance 2 (R2) 5.96 5.83 5.98 6.11
Resistance 1 (R1) 5.83 5.75 5.90 5.88 6.08
Pivot Point 5.62 5.62 5.65 5.64 5.62
Support 1 (S1) 5.49 5.49 5.56 5.54 5.34
Support 2 (S2) 5.28 5.41 5.30 5.31
Support 3 (S3) 5.15 5.28 5.29
Support 4 (S4) 5.20